Table 2. Disease severity, clinical management and treatment regimens compared between patients diagnosed with SARS-CoV-2 infection in the early and late preterm period.
| 23–34 weeks ( n = 36) | 34–37 weeks ( n = 29) | p -Value | |
|---|---|---|---|
| Delivery during admission, n (%) | 7 (19.4) | 18 (62) | 0.001 |
| Delivered to date, n (%) | 20 (55.6) | 27 (93.1) | 0.002 |
| SARS-CoV-2 severity, n (%) | |||
| Positive test with no typical SARS-CoV-2 symptoms | 3 (8.3) | 11 (37.9) | 0.03 |
| Mild | 12 (33.3) | 8 (27.6) | |
| Severe | 16 (44.5) | 8 (27.6) | |
| Critical | 5 (13.9) | 2 (6.9) | |
| Disposition, n (%) | |||
| Outpatient: not admitted | 13 (36.1) | 8 (27.6) | 0.02 |
| Inpatient: antepartum | 13 (36.1) | 5 (17.3) | |
| Inpatient: L&D | 6 (16.7) | 15 (51.7) | |
| Inpatient: ICU | 4 (11.1) | 1 (3.4) | |
| Length of hospital stay, median (IQR) (d) | 4 (2–7) | 4 (3–4) | 0.8 |
| Treatment, n (%) | |||
| Antibiotics | 9 (25) | 5 (17.3) | 0.55 |
| Antimalarial | 10 (27.8) | 7 (24.1) | 0.78 |
| Steroids | 4 (11.1) | 0 (0) | 0.12 |
| Anti-interleukin | 4 (11.1) | 0 (0) | 0.12 |
| None | 12 (33.3) | 22 (75.9) | 0.001 |
Abbreviations: ICU, intensive care unit; IQR, interquartile range; L&D, labor and delivery; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.